Report Code: 10246 | Available Format: PDF | Pages: 288
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by therapeutic area
1.4.2. Market size breakdown, by technology
1.4.3. Market size breakdown, by region
1.4.4. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
Chapter 6. Global Market
6.1. Overview
6.2. Market Revenue, by Therapeutic Area (2019–2030)
6.3. Market Revenue, by Technology (2019–2030)
6.4. Market Revenue, by Region (2019–2030)
Chapter 7. North America Market
7.1. Overview
7.2. Market Revenue, by Therapeutic Area (2019–2030)
7.3. Market Revenue, by Technology (2019–2030)
7.4. Market Revenue, by Country (2019–2030)
Chapter 8. Europe Market
8.1. Overview
8.2. Market Revenue, by Therapeutic Area (2019–2030)
8.3. Market Revenue, by Technology (2019–2030)
8.4. Market Revenue, by Country (2019–2030)
Chapter 9. APAC Market
9.1. Overview
9.2. Market Revenue, by Therapeutic Area (2019–2030)
9.3. Market Revenue, by Technology (2019–2030)
9.4. Market Revenue, by Country (2019–2030)
Chapter 10. LATAM Market
10.1. Overview
10.2. Market Revenue, by Therapeutic Area (2019–2030)
10.3. Market Revenue, by Technology (2019–2030)
10.4. Market Revenue, by Country (2019–2030)
Chapter 11. MEA Market
11.1. Overview
11.2. Market Revenue, by Therapeutic Area (2019–2030)
11.3. Market Revenue, by Technology (2019–2030)
11.4. Market Revenue, by Country (2019–2030)
Chapter 12. U.S. Market
12.1. Overview
12.2. Market Revenue, by Therapeutic Area (2019–2030)
12.3. Market Revenue, by Technology (2019–2030)
Chapter 13. Canada Market
13.1. Overview
13.2. Market Revenue, by Therapeutic Area (2019–2030)
13.3. Market Revenue, by Technology (2019–2030)
13.4. Germany Market
13.5. Overview
13.6. Market Revenue, by Therapeutic Area (2019–2030)
13.7. Market Revenue, by Technology (2019–2030)
Chapter 14. France Market
14.1. Overview
14.2. Market Revenue, by Therapeutic Area (2019–2030)
14.3. Market Revenue, by Technology (2019–2030)
Chapter 15. U.K. Market
15.1. Overview
15.2. Market Revenue, by Therapeutic Area (2019–2030)
15.3. Market Revenue, by Technology (2019–2030)
Chapter 16. Italy Market
16.1. Overview
16.2. Market Revenue, by Therapeutic Area (2019–2030)
16.3. Market Revenue, by Technology (2019–2030)
Chapter 17. Spain Market
17.1. Overview
17.2. Market Revenue, by Therapeutic Area (2019–2030)
17.3. Market Revenue, by Technology (2019–2030)
Chapter 18. Japan Market
18.1. Overview
18.2. Market Revenue, by Therapeutic Area (2019–2030)
18.3. Market Revenue, by Technology (2019–2030)
Chapter 19. China Market
19.1. Overview
19.2. Market Revenue, by Therapeutic Area (2019–2030)
19.3. Market Revenue, by Technology (2019–2030)
Chapter 20. India Market
20.1. Overview
20.2. Market Revenue, by Therapeutic Area (2019–2030)
20.3. Market Revenue, by Technology (2019–2030)
Chapter 21. Australia Market
21.1. Overview
21.2. Market Revenue, by Therapeutic Area (2019–2030)
21.3. Market Revenue, by Technology (2019–2030)
Chapter 22. South Korea Market
22.1. Overview
22.2. Market Revenue, by Therapeutic Area (2019–2030)
22.3. Market Revenue, by Technology (2019–2030)
Chapter 23. Brazil Market
23.1. Overview
23.2. Market Revenue, by Therapeutic Area (2019–2030)
23.3. Market Revenue, by Technology (2019–2030)
Chapter 24. Mexico Market
24.1. Overview
24.2. Market Revenue, by Therapeutic Area (2019–2030)
24.3. Market Revenue, by Technology (2019–2030)
Chapter 25. Saudi Arabia Market
25.1. Overview
25.2. Market Revenue, by Therapeutic Area (2019–2030)
25.3. Market Revenue, by Technology (2019–2030)
Chapter 26. South Africa Market
26.1. Overview
26.2. Market Revenue, by Therapeutic Area (2019–2030)
26.3. Market Revenue, by Technology (2019–2030)
Chapter 27. U.A.E. Market
27.1. Overview
27.2. Market Revenue, by Therapeutic Area (2019–2030)
27.3. Market Revenue, by Technology (2019–2030)
Chapter 28. Competitive Landscape
28.1. List of Market Players and their Offerings
28.2. Competitive Benchmarking of Key Players
28.3. Product Benchmarking of Key Players
28.4. Recent Strategic Developments
Chapter 29. Company Profiles
29.1. F. Hoffman-La Roche Ltd.
29.1.1. Business overview
29.1.2. Product and service offerings
29.1.3. Key financial summary
29.2. Kyowa Kirin Co. Ltd.
29.2.1. Business overview
29.2.2. Product and service offerings
29.2.3. Key financial summary
29.3. Seagen Inc.
29.3.1. Business overview
29.3.2. Product and service offerings
29.3.3. Key financial summary
29.4. ImmunoGen Inc.
29.4.1. Business overview
29.4.2. Product and service offerings
29.4.3. Key financial summary
29.5. Takeda Pharmaceutical Company Limited
29.5.1. Business overview
29.5.2. Product and service offerings
29.5.3. Key financial summary
29.6. Amgen Inc.
29.6.1. Business overview
29.6.2. Product and service offerings
29.6.3. Key financial summary
29.7. Pfizer Inc.
29.7.1. Business overview
29.7.2. Product and service offerings
29.7.3. Key financial summary
29.8. Catalent Inc.
29.8.1. Business overview
29.8.2. Product and service offerings
29.8.3. Key financial summary
29.9. AstraZeneca Plc.
29.9.1. Business overview
29.9.2. Product and service offerings
29.9.3. Key financial summary
29.10. Xencor Inc.
29.10.1. Business overview
29.10.2. Product and service offerings
29.10.3. Key financial summary
Chapter 30. Appendix
30.1. Abbreviations
30.2. Sources and References
30.3. Related Reports
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws